Form 4 for EFX Equifax
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001225208-25-001576 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-10 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +13.5K | 122.9K | +12% | $0 |
| DM | 2025-02-12 | 2025-02-10 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +45.2K | 21.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | A | A | 13,524 | $0.00 | 122,929 | D | — | — | (F1) Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 147 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Option/Right to Buy | 2025-02-10 | A | A | 23,519 | $0.00 | 23,519 | D | $303.48 · 2028-02-10 to 2033-02-10 | 23,519 Common Stock | |
| 3 | Derivative | Stock Option/Right to Buy | 2025-02-10 | A | A | 21,668 | $0.00 | 21,668 | D | $278.19 · 2028-02-10 to 2033-02-10 | 21,668 Common Stock |